Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL713217 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL715364 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL712408 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL714357 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL713038 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL716379 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL403954 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| SCHEMBL715943 | 1.00 | TSHR (0.39) | TSHRKDM4ETDP1USP2MAPT | |
| Water SCHEMBL15939211 | 0.98 | TSHR (0.38) | TSHRKDM4ETDP1USP2MAPT | |
| Ammonia Solution, Strong SCHEMBL6997853 | 0.98 | TSHR (0.38) | TSHRKDM4ETDP1USP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-111848832-B | Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof | 苏州大学 | 2024-02-20 | — | — | CN | claimed |
| CN-111892667-B | Application of fluorine-containing compound modified cationic polymer in preparation of medical cosmetic and health care products | 苏州大学 | 2024-02-20 | — | — | CN | claimed |
| CN-109957880-B | Creel for warp knitting spacer fabric production | 福建省晋江市华宇织造有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-108950851-B | Production method of creel warp knitting spacer mesh cloth | 福建省晋江市华宇织造有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-111848831-B | Application of fluorine-containing compound modified cationic polymer in preparation of vaccine medicine | 苏州大学 | 2023-06-13 | — | — | CN | claimed |
| CN-113121792-B | UV-cured fluorine-modified waterborne epoxy resin and preparation method thereof | 上海三桐材料科技有限公司 | 2023-06-09 | — | — | CN | claimed |
| CN-115919795-A | Non-interface self-assembly microcapsule and preparation method and application thereof | 复旦大学附属金山医院(上海市金山区眼病防治所、上海市金山区核化伤害应急救治中心) | 2023-04-07 | — | — | CN | claimed |
| EP-4095162-A1 | APPLICATION OF AND PREPARATION METHOD FOR CATIONIC POLYMER MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER | Soochow University (CN) | 2022-11-30 | — | — | EP | claimed |
| US-20070075290-A1 | Filterable Surfactant Composition | GENERAL CHEMICAL PERFORMANCE PRODUCTS LLC (US) | 2007-04-05 | — | — | US | claimed |
| US-7112289-B2 | Etchants containing filterable surfactant | GENERAL CHEMICAL PERFORMANCE PRODUCTS LLC (US) | 2006-09-26 | — | — | US | claimed |
| US-20060097218-A1 | Etchants containing filterable surfactant | GENERAL CHEMICAL PERFORMANCE PRODUCTS LLC | 2006-05-11 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1288727-A2 | Polydimethylsiloxane and fluorosurfactant fusing release agent | Xerox Corporation (US) | 2003-03-05 | — | — | EP | claimed |
| US-6515069-B1 | A release agent having a polydimethylsiloxane and a fluorosurfactant other than a silicone glycol polymer, a perfluoroalkylsubstituted polyethylene glycol, or a perfluoroalkylsubstituted silane. | XEROX CORPORATION | 2003-02-04 | — | — | US | claimed |
| US-6383274-B1 | Ink jet ink compositions and printing processes | XEROX CORPORATION | 2002-05-07 | — | — | US | claimed |
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | TSHR 4082/4885KDM4E 1567/4885TDP1 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.